Citation: Lu Tang, Mengying Xie, Jing Li, Yijun Mei, Yuqi Cao, Qiaqia Xiao, Haijuan Dong, Yuhui Zhang, Wei Wang. Leveraging nano-engineered mesenchymal stem cells for intramedullary spinal cord tumor treatment[J]. Chinese Chemical Letters, ;2023, 34(5): 107801. doi: 10.1016/j.cclet.2022.107801 shu

Leveraging nano-engineered mesenchymal stem cells for intramedullary spinal cord tumor treatment

    * Corresponding author.
    ** Corresponding author at: Department of Pharmaceutics, State Key Laboratory of Natural Medicines, School of Pharmacy, China Pharmaceutical University, Nanjing 210009, China.
    E-mail addresses: yuhuizhang_2003@126.com (Y. Zhang), wangcpu209@cpu.edu.cn (W. Wang).
    1 These authors contributed equally to this work.
  • Received Date: 3 May 2022
    Revised Date: 20 August 2022
    Accepted Date: 2 September 2022
    Available Online: 6 September 2022

Figures(5)

Metrics
  • PDF Downloads(6)
  • Abstract views(251)
  • HTML views(32)

通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索
Address:Zhongguancun North First Street 2,100190 Beijing, PR China Tel: +86-010-82449177-888
Powered By info@rhhz.net

/

DownLoad:  Full-Size Img  PowerPoint
Return